Cargando…

JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy

T cells are critical mediators of antitumor immunity and a major target for cancer immunotherapy. Antibody blockade of inhibitory receptors such as PD-1 can partially restore the activity of tumor-infiltrating lymphocytes (TILs). However, the activation signals required to promote TIL responses are...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGraw, Joseph M., Thelen, Flavian, Hampton, Eric N., Bruno, Nelson E., Young, Travis S., Havran, Wendy L., Witherden, Deborah A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404475/ https://www.ncbi.nlm.nih.gov/pubmed/34427588 http://dx.doi.org/10.1084/jem.20202644

Ejemplares similares

γδ T cell costimulatory ligands in antitumor immunity
por: McGraw, Joseph M., et al.
Publicado: (2022)

Coreceptors and Their Ligands in Epithelial γδ T Cell Biology
por: Witherden, Deborah A., et al.
Publicado: (2018)

Multiple Receptor-Ligand Interactions Direct Tissue-Resident γδ T Cell Activation
por: Witherden, Deborah. A., et al.
Publicado: (2014)

The Role of Tissue-resident γδ T Cells in Stress Surveillance and Tissue Maintenance
por: Johnson, Margarete D., et al.
Publicado: (2020)

γδ T cell–induced hyaluronan production by epithelial cells regulates inflammation
por: Jameson, Julie M., et al.
Publicado: (2005)

JAML mediates monocyte and CD8 T cell migration across the brain endothelium
por: Alvarez, Jorge Iván, et al.
Publicado: (2015)

Get in Touch With Dendritic Epithelial T Cells!
por: Thelen, Flavian, et al.
Publicado: (2020)

Protection against colitis by CD100 dependent modulation of intraepithelial γδ T lymphocyte function
por: Meehan, Terrence F., et al.
Publicado: (2013)

cDNA Sequence and Fab Crystal Structure of HL4E10, a Hamster IgG Lambda Light Chain Antibody Stimulatory for γδ T Cells
por: Verdino, Petra, et al.
Publicado: (2011)

Stimulation of hair follicle stem cell proliferation through an IL-1 dependent activation of γδT-cells
por: Lee, Pedro, et al.
Publicado: (2017)

Neutrophil-derived JAML Inhibits Repair of Intestinal Epithelial Injury During Acute Inflammation
por: Weber, Dominique A., et al.
Publicado: (2014)

JAML promotes acute kidney injury mainly through a macrophage-dependent mechanism
por: Huang, Wei, et al.
Publicado: (2022)

Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application
por: Miyashita, Masatsugu, et al.
Publicado: (2021)

Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma
por: Fang, Likui, et al.
Publicado: (2022)

The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
por: Legut, Mateusz, et al.
Publicado: (2015)

γδ T Cells and Their Potential for Immunotherapy
por: Wu, Yan-Ling, et al.
Publicado: (2014)

γδ T cells in cancer immunotherapy
por: Zou, Chang, et al.
Publicado: (2016)

γδ T Cell Immunotherapy—A Review
por: Kobayashi, Hirohito, et al.
Publicado: (2015)

T Cell Receptor (TCR)-induced Death of Immature CD4(+)CD8(+) Thymocytes by Two Distinct Mechanisms Differing in Their Requirement for CD28 Costimulation: Implications for Negative Selection in the Thymus
por: Punt, Jennifer A., et al.
Publicado: (1997)

CD8(+)脾脏γδT细胞淋巴瘤1例
Publicado: (2023)

Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
por: Oberg, Hans-Heinrich, et al.
Publicado: (2014)

γδ T Cells: The Ideal Tool for Cancer Immunotherapy
por: Yazdanifar, Mahboubeh, et al.
Publicado: (2020)

3D modelling of γδ T‐cell immunotherapy
por: Hull, Caroline M., et al.
Publicado: (2022)

The emerging role of γδ T cells in cancer immunotherapy
por: Nussbaumer, Oliver, et al.
Publicado: (2019)

γδ T cells in immunotherapies for B-cell malignancies
por: Rimailho, Léa, et al.
Publicado: (2023)

Lymph node γδ and αβ CD8(+) T cells share migratory properties
por: Ugur, Milas, et al.
Publicado: (2018)

γδT Cells Are Required for CD8(+) T Cell Response to Vaccinia Viral Infection
por: Dai, Rui, et al.
Publicado: (2021)

Circulating CD4(+) Treg, CD8(+) Treg, and CD3(+) γδ T Cell Subpopulations in Ovarian Cancer
por: Li, Rong, et al.
Publicado: (2023)

Harnessing Antitumor CD4(+) T Cells for Cancer Immunotherapy
por: Ben Khelil, Myriam, et al.
Publicado: (2022)

Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy
por: Burnham, Rebecca E., et al.
Publicado: (2020)

Data characterizing diurnal rhythms in the number of peripheral CD8α(−) and CD8α(+) γδ T cells in domestic pigs
por: Engert, Larissa C., et al.
Publicado: (2017)

Multifunctional γδ T cells and their receptors for targeted anticancer immunotherapy
por: Scheper, Wouter, et al.
Publicado: (2013)

Immunotherapy of acute myeloid leukemia based on γδ T cells
por: Gertner-Dardenne, Julie, et al.
Publicado: (2012)

Cancer Immunotherapy Using γδT Cells: Dealing with Diversity
por: Scheper, Wouter, et al.
Publicado: (2014)

Current Advances in γδ T Cell-Based Tumor Immunotherapy
por: Lo Presti, Elena, et al.
Publicado: (2017)

Γδ T Cell-Based Immunotherapy in Melanoma: State of the Art
por: Toia, F., et al.
Publicado: (2019)

γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends
por: Barros, Mateus de Souza, et al.
Publicado: (2021)

A close look at current γδ T-cell immunotherapy
por: Ma, Ling, et al.
Publicado: (2023)

Biological characteristics of γδT cells and application in tumor immunotherapy
por: Zhu, Renhong, et al.
Publicado: (2023)

γδ T cells: origin and fate, subsets, diseases and immunotherapy
por: Hu, Yi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_faq8bn0qo9kks1k81eu9eanp29